Mayo Clinic researcher Keith Knutson and his team have received investigational new drug approval from the Food and Drug Administration for two new vaccines that mobilize the body’s defense mechanisms to destroy cancer cells. The vaccines are among the first aimed at preventing cancer recurrence. The approval clears the way for Phase I clinical trials later this year with women treated for ovarian or breast cancer.
- Journalists-Become a Mayo Clinic News Network member The journalists' multimedia source for health, science and research information
Request an Appointment